Related Experiment Videos
Measurement of [3H]PN200-110 and [125I]omega-conotoxin MVIIA binding
1University Department of Anaesthesia, Leicester Royal Infirmary, UK.
Methods in Molecular Biology (Clifton, N.J.)
|March 19, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic.
British journal of anaesthesia·2018
Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor.
British journal of pharmacology·2018
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.
British journal of pharmacology·2018
Evidence for nociceptin/orphanin FQ (NOP) but not µ (MOP), δ (DOP) or κ (KOP) opioid receptor mRNA in whole human blood.
British journal of anaesthesia·2016
High-Throughput Sample Preparation for Plant (Phospho) Proteomics.
Methods in molecular biology (Clifton, N.J.)·2026
Enrichment of Arabidopsis Plasma Membrane Proteins by Sequential Differential Centrifugation.
Methods in molecular biology (Clifton, N.J.)·2026
Single-Cell RNA-Sequencing in Nodulated Roots of Medicago truncatula.
Methods in molecular biology (Clifton, N.J.)·2026
Gene Expression Analysis from Specific Root Cell Types.
Methods in molecular biology (Clifton, N.J.)·2026
Whole-Mount In Situ Hybridization Using Microwave Treatment.
Methods in molecular biology (Clifton, N.J.)·2026
Mapping Labile Fe2+ and Fe3+ in Living Arabidopsis thaliana Roots: Imaging and Quantification.
Methods in molecular biology (Clifton, N.J.)·2026
Chlorogenic Acid Derivative B11 Inhibits Glioma Proliferation by Targeting MST4 to Regulate Oxidative Stress.
Molecular carcinogenesis·2026
Pancreatic Cancer KRAS Breakthrough: Drug Graveyard No More.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Targeting RAS in pancreatic cancer.
Cancer·2026
Late effects after novel therapies for childhood cancer: Anticipating the future landscape of health outcomes for survivors.
Journal of the National Cancer Institute·2026